Clinical trials are crucial for ensuring that nanotechnology-based treatments are both safe and effective. They help in determining the appropriate dosages, understanding the pharmacokinetics and pharmacodynamics, and identifying any potential adverse effects. Without clinical trials, it would be challenging to gain regulatory approval for new nanomedicines.
